Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 313-319

  Lee, Minhyung ^a   Park, Hyewon ^a   Youn, Jeehee ^a   Eun, Taex Oh ^a   Ko, Kyungsoo ^b   Kim, Sungwan ^a,c   Park, Yongsoo ^a  

^a Hanyang University   (South Korea)

^b Inje University   (South Korea)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

IL 10; NF B binding sites; NOD mouse; Nonviral gene delivery; Type 1 diabetes

Indexed keywords

DRUG CARRIER; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PROMOTER REGION; PROTEIN BLOOD LEVEL; SIMIAN VIRUS 40; TREATMENT OUTCOME;

ANIMALIA;

EID: 33845709923     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.048     Document Type: Conference Paper

References (11)

1. HAN, S. et al. 2000. Development of biomaterials for gene therapy. Mol. Ther. 2: 302-317.
2. LEE, M. & S.W. KIM. 2005. Polyethylene glycol-conjugated copolymers forplasmid DNA delivery. Pharm. Res. 22: 1-10.
3. KOH, J.J. et al. 2000. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene. Ther. 7: 2099-2104.
4. Ko, K. et al. 2001. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol. Ther. 4: 313-316.
5. OH, S. et al. 2003. GLP-1 gene delivery for the treatment of type 2 diabetes. Mol. Ther. 7: 478-483.
6. LEE, M. et al. 2003. Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. J. Control Release 88: 333-342.
7. NISHIKAWA, M. & L. HUANG. 2001. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12: 861-870.
8. BARNES, P.J. & M. KARIN. 1997. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071.
9. MESIKA, A. et al. 2001. A regulated, NFκB-assisted import of plasmid DNA into mammalian cell nuclei. Mol. Ther. 3: 653-657.
10. LEITER, E.H. 1996. Lessons from the animal models: the NOD mouse. In Prediction, Prevention and Genetic Counseling in IDDM. J.P. Palmer, Ed.: 201-226. John Wiley & Sons. Chichester.
11. CAMERON, M.J. et al. 2000. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. Gene Ther. 7: 1840-1846.